Gera L - Search Results

1

In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors.

Hanson WL, McCullough RG, Selig WM, Wieczorek M, Ross S, Whalley ET, Stewart JM, Gera L. Hanson WL, et al. Among authors: gera l. Immunopharmacology. 1996 Jun;33(1-3):191-3. doi: 10.1016/0162-3109(96)00037-9. Immunopharmacology. 1996. PMID: 8856147 No abstract available.

2

Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958.

Gera L, Stewart JM, Fortin JP, Morissette G, Marceau F. Gera L, et al. Int Immunopharmacol. 2008 Feb;8(2):289-92. doi: 10.1016/j.intimp.2007.06.006. Epub 2007 Jul 5. Int Immunopharmacol. 2008. PMID: 18182242

3

A new generation of bradykinin antagonists.

Stewart JM, Gera L, Hanson W, Zuzack JS, Burkard M, McCullough R, Whalley ET. Stewart JM, et al. Among authors: gera l. Immunopharmacology. 1996 Jun;33(1-3):51-60. doi: 10.1016/0162-3109(96)00084-7. Immunopharmacology. 1996. PMID: 8856115

4

A new class of bradykinin antagonists containing indanylglycine.

Gera L, Stewart JM. Gera L, et al. Immunopharmacology. 1996 Jun;33(1-3):174-7. doi: 10.1016/0162-3109(96)00098-7. Immunopharmacology. 1996. PMID: 8856143 No abstract available.

5

A new class of potent bradykinin antagonist dimers.

Gera L, Stewart JM, Whalley E, Burkard M, Zuzack JS. Gera L, et al. Immunopharmacology. 1996 Jun;33(1-3):178-82. doi: 10.1016/0162-3109(96)00099-9. Immunopharmacology. 1996. PMID: 8856144 No abstract available.

6

New bradykinin antagonists having very high potency at B1 receptors.

Gera L, Stewart JM, Whalley ET, Burkard M, Zuzack JS. Gera L, et al. Immunopharmacology. 1996 Jun;33(1-3):183-5. doi: 10.1016/0162-3109(96)00100-2. Immunopharmacology. 1996. PMID: 8856145 No abstract available.

7

Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors.

Burkard M, Zuzack JS, Jones S, Francis M, Whalley ET, Stewart JM, Gera L. Burkard M, et al. Among authors: gera l. Immunopharmacology. 1996 Jun;33(1-3):186-90. doi: 10.1016/0162-3109(96)00036-7. Immunopharmacology. 1996. PMID: 8856146

8

Novel bradykinin antagonist dimers for the treatment of human lung cancers.

Chan D, Gera L, Helfrich B, Helm K, Stewart J, Whalley E, Bunn P. Chan D, et al. Among authors: gera l. Immunopharmacology. 1996 Jun;33(1-3):201-4. doi: 10.1016/0162-3109(96)00040-9. Immunopharmacology. 1996. PMID: 8856150 No abstract available.

9

Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications.

Stewart JM, Gera L, Chan DC, Whalley ET, Hanson WL, Zuzack JS. Stewart JM, et al. Among authors: gera l. Immunopharmacology. 1997 Jun;36(2-3):167-72. doi: 10.1016/s0162-3109(97)00017-9. Immunopharmacology. 1997. PMID: 9228542 Review.

10

Oral activity of peptide bradykinin antagonists following intragastric administration in the rat.

Whalley ET, Hanson WL, Stewart JM, Gera L. Whalley ET, et al. Among authors: gera l. Can J Physiol Pharmacol. 1997 Jun;75(6):629-32. Can J Physiol Pharmacol. 1997. PMID: 9276140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters